BlueCove Limited
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 1.6m | <1m | 4.0m | 5.6m | 15.4m | 6.3m |
% growth | - | (98 %) | 14832 % | 38 % | 176 % | (59 %) |
EBITDA | (4.5m) | (11.4m) | (12.3m) | (12.4m) | (4.7m) | - |
% EBITDA margin | (280 %) | (42385 %) | (304 %) | (222 %) | (31 %) | - |
Profit | (4.2m) | (10.8m) | (11.2m) | (11.8m) | (4.3m) | - |
% profit margin | (265 %) | (39928 %) | (278 %) | (211 %) | (28 %) | - |
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Growth Equity VC | |
Total Funding | - |
Recent News about BlueCove Limited
EditBlueCove is a scientific asset management firm established in 2018, focusing on fixed income markets. The company applies the scientific method to develop state-of-the-art fixed income offerings for its client investors. BlueCove operates in the financial services sector, specifically targeting the $60 trillion fixed income industry. Its clientele primarily includes institutional investors seeking innovative and data-driven investment strategies. The firm is authorized and regulated by the Financial Conduct Authority in the United Kingdom, ensuring compliance with stringent financial regulations.
BlueCove's business model revolves around providing scientific active investing solutions, which serve as an alternative and complement to both passive and traditional active investing. By leveraging advanced research and data analytics, BlueCove aims to deliver superior investment performance and risk management. The company generates revenue through management fees and performance-based incentives, aligning its interests with those of its clients.
Keywords: scientific investing, fixed income, asset management, institutional investors, data-driven strategies, financial services, UK regulated, active investing, investment performance, risk management.